Answers are grounded in this paper and cite their sources.
Systemic inflammation is pervasive in advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD), where it is a central component of the “malnutrition–inflammation–atherosclerosis” complex. Elevated C-reactive protein (CRP) and related biomarkers in this setting track with protein-energy wasting, vascular calcification, and an excess burden of cardiovascular events and premature death. Yet key questions remain unsettled: how far does inflammation independently shape cardiovascular and renal trajectories in non-dialysis CKD, and can simple markers such as high-sensitivity CRP (hsCRP) meaningfully refine risk stratification beyond traditional factors and kidney measures?
No takes yet. Share an insight, caveat, or question.
Zoccali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: